CAMP4 Therapeutics Corporation
CAMP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $60,479 | $29,232 | $78,020 | $101,817 |
| - Cash | $75,255 | $39,052 | $49,323 | $64,039 |
| + Debt | $6,346 | $7,124 | $7,871 | $8,648 |
| Enterprise Value | -$8,430 | -$2,696 | $36,568 | $46,426 |
| Revenue | $795 | $1,497 | $858 | $652 |
| % Growth | -46.9% | 74.5% | 31.6% | – |
| Gross Profit | $379 | $1,497 | $858 | $652 |
| % Margin | 47.7% | 100% | 100% | 100% |
| EBITDA | -$14,683 | -$12,598 | -$12,679 | -$13,616 |
| % Margin | -1,846.9% | -841.5% | -1,477.7% | -2,088.3% |
| Net Income | -$15,099 | -$12,587 | -$12,433 | -$13,279 |
| % Margin | -1,899.2% | -840.8% | -1,449.1% | -2,036.7% |
| EPS Diluted | -0.55 | -0.62 | -0.64 | -0.68 |
| % Growth | 11.3% | 3.1% | 5.9% | – |
| Operating Cash Flow | -$11,217 | -$10,343 | -$14,286 | -$11,288 |
| Capital Expenditures | $0 | $0 | -$279 | -$263 |
| Free Cash Flow | -$11,217 | -$10,343 | -$14,565 | -$11,551 |